MCMedicalCodingSoftware
Z51.12

Z51.12: Encounter for antineoplastic immunotherapy

Billable / specific codeICD-10-CMPOA exempt

Z51.12 is a billable, specific ICD-10-CM code for encounter for antineoplastic immunotherapy. It is valid for submission on a claim.

Check Z51.12 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above Z51.12

A category’s note binds every code beneath it.

Written on Z51: Encounter for other aftercare and medical care

  • follow-up examination after treatment (Z08-Z09)

Excludes2 inherited from the categories above Z51.12

Not part of this code, but both may be coded when both are present.

Written on Z51.1: Encounter for antineoplastic chemotherapy and immunotherapy

  • encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

Z51.12 is named in 8 Medicare coverage policies: 8 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)
  • A56494Billing and Coding: Cardiovascular Nuclear Medicine
  • A56580Billing and Coding: Computerized Axial Tomography (CT), Thorax
  • A56743Billing and Coding: Cardiovascular Nuclear Medicine

Alphabetic index entries that lead here

  • Encounter›immunotherapy for neoplasm
  • Immunotherapy›antineoplastic

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under Z51.1

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.